Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans

References

• Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, et al. Neutrophil activation by monomeric interleukin-8. Science 1994; 264:90 - 2; http://dx.doi.org/10.1126/science.8140420; PMID: 8140420
   PubMed Web of Science ®Google Scholar
• Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002; 82:521 - 33; http://dx.doi.org/10.1038/labinvest.3780446; PMID: 12003992
   PubMed Web of Science ®Google Scholar
• Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006; 20:9 - 22; http://dx.doi.org/10.1096/fj.05-4682rev; PMID: 16394262
   PubMed Web of Science ®Google Scholar
• Walker A, Ward C, Taylor EL, Dransfield I, Hart SP, Haslett C, et al. Regulation of neutrophil apoptosis and removal of apoptotic cells. Curr Drug Targets Inflamm Allergy 2005; 4:447 - 54; http://dx.doi.org/10.2174/1568010054526278; PMID: 16101521
   PubMedGoogle Scholar
• Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006; 129:1673 - 82; http://dx.doi.org/10.1378/chest.129.6.1673; PMID: 16778289
   PubMed Web of Science ®Google Scholar
• Krysko DV, D’Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006; 11:1709 - 26; http://dx.doi.org/10.1007/s10495-006-9527-8; PMID: 16951923
   PubMed Web of Science ®Google Scholar
• Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171:2 - 8; http://dx.doi.org/10.2353/ajpath.2007.070135; PMID: 17591947
   PubMed Web of Science ®Google Scholar
• Franz S, Hoeve MA, Wickert S, Janko C, Dransfield I. Clearance of apo Nph induces an immunosuppressive response in pro-inflammatory type-1 and anti-inflammatory type-2 MPhi. Autoimmunity 2009; 42:275 - 7; http://dx.doi.org/10.1080/08916930902828080; PMID: 19811275
   PubMed Web of Science ®Google Scholar
• Arnhold J, Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 2010; 500:92 - 106; http://dx.doi.org/10.1016/j.abb.2010.04.008; PMID: 20399194
   PubMed Web of Science ®Google Scholar
• Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Three-dimensional structure of interleukin 8 in solution. Biochemistry 1990; 29:1689 - 96; http://dx.doi.org/10.1021/bi00459a004; PMID: 2184886
   PubMed Web of Science ®Google Scholar
• Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM. Determination of the secondary structure of interleukin-8 by nuclear magnetic resonance spectroscopy. J Biol Chem 1989; 264:18907 - 11; PMID: 2681204
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307:97 - 101; http://dx.doi.org/10.1016/0014-5793(92)80909-Z; PMID: 1639201
   PubMed Web of Science ®Google Scholar
• Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, et al. Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A 1991; 88:502 - 6; http://dx.doi.org/10.1073/pnas.88.2.502; PMID: 1988949
   PubMed Web of Science ®Google Scholar
• Grasberger BL, Gronenborn AM, Clore GM. Analysis of the backbone dynamics of interleukin-8 by 15N relaxation measurements. J Mol Biol 1993; 230:364 - 72; http://dx.doi.org/10.1006/jmbi.1993.1152; PMID: 8464050
   PubMed Web of Science ®Google Scholar
• Rajarathnam K, Clark-Lewis I, Dewald B, Baggiolini M, Sykes BD. 1H NMR evidence that Glu-38 interacts with the N-terminal functional domain in interleukin-8. FEBS Lett 1996; 399:43 - 6; http://dx.doi.org/10.1016/S0014-5793(96)01277-X; PMID: 8980116
   PubMed Web of Science ®Google Scholar
• Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 1994; 352:231 - 5; http://dx.doi.org/10.1016/0014-5793(94)00952-X; PMID: 7925979
   PubMed Web of Science ®Google Scholar
• Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 2008; 205:2085 - 97; http://dx.doi.org/10.1084/jem.20080305; PMID: 18710930
   PubMed Web of Science ®Google Scholar
• Mortier A, Gouwy M, Van Damme J, Proost P. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 2011; 317:642 - 54; http://dx.doi.org/10.1016/j.yexcr.2010.11.016; PMID: 21146523
   PubMed Web of Science ®Google Scholar
• Burrows SD, Doyle ML, Murphy KP, Franklin SG, White JR, Brooks I, et al. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 1994; 33:12741 - 5; http://dx.doi.org/10.1021/bi00209a002; PMID: 7947677
   PubMed Web of Science ®Google Scholar
• Das ST, Rajagopalan L, Guerrero-Plata A, Sai J, Richmond A, Garofalo RP, et al. Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS One 2010; 5:e11754; http://dx.doi.org/10.1371/journal.pone.0011754; PMID: 20668677
   PubMedGoogle Scholar
• Clark-Lewis I, Schumacher C, Baggiolini M, Moser B. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 1991; 266:23128 - 34; PMID: 1744111
   PubMed Web of Science ®Google Scholar
• Rajarathnam K, Clark-Lewis I, Sykes BD. 1H NMR studies of interleukin 8 analogs: characterization of the domains essential for function. Biochemistry 1994; 33:6623 - 30; http://dx.doi.org/10.1021/bi00187a032; PMID: 8204599
   PubMed Web of Science ®Google Scholar
• Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 1994; 269:16075 - 81; PMID: 8206907
   PubMed Web of Science ®Google Scholar
• Gerber N, Lowman H, Artis DR, Eigenbrot C. Receptor-binding conformation of the “ELR” motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution. Proteins 2000; 38:361 - 7; http://dx.doi.org/10.1002/(SICI)1097-0134(20000301)38:4<361::AID-PROT2>3.0.CO;2-0; PMID: 10707023
   PubMed Web of Science ®Google Scholar
• Mortier A, Van Damme J, Proost P. Regulation of chemokine activity by posttranslational modification. Pharmacol Ther 2008; 120:197 - 217; http://dx.doi.org/10.1016/j.pharmthera.2008.08.006; PMID: 18793669
   PubMed Web of Science ®Google Scholar
• Kuschert GSV, Coulin F, Power CA, Proudfoot AEI, Hubbard RE, Hoogewerf AJ, et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999; 38:12959 - 68; http://dx.doi.org/10.1021/bi990711d; PMID: 10504268
   PubMed Web of Science ®Google Scholar
• Lortat-Jacob H, Grosdidier A, Imberty A. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci U S A 2002; 99:1229 - 34; http://dx.doi.org/10.1073/pnas.032497699; PMID: 11830659
   PubMed Web of Science ®Google Scholar
• Pichert A, Samsonov SA, Theisgen S, Thomas L, Baumann L, Schiller J, et al. Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology 2012; 22:134 - 45; http://dx.doi.org/10.1093/glycob/cwr120; PMID: 21873605
   PubMed Web of Science ®Google Scholar
• Hébert CA, Vitangcol RV, Baker JB. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 1991; 266:18989 - 94; PMID: 1918013
   PubMed Web of Science ®Google Scholar
• Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, et al. Structure-activity relationships of chemokines. J Leukoc Biol 1995; 57:703 - 11; PMID: 7759949
   PubMed Web of Science ®Google Scholar
• Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253:1278 - 80; http://dx.doi.org/10.1126/science.1840701; PMID: 1840701
   PubMed Web of Science ®Google Scholar
• Morohashi H, Miyawaki T, Nomura H, Kuno K, Murakami S, Matsushima K, et al. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 1995; 57:180 - 7; PMID: 7829970
   PubMed Web of Science ®Google Scholar
• Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52:145 - 76; PMID: 10699158
   PubMed Web of Science ®Google Scholar
• Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, Ballman KK, et al. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 2003; 170:5244 - 51; PMID: 12734373
   PubMed Web of Science ®Google Scholar
• Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, Carroll TP, et al. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 2010; 120:4236 - 50; http://dx.doi.org/10.1172/JCI41196; PMID: 21060150
   PubMed Web of Science ®Google Scholar
• Hoogewerf AJ, Kuschert GSV, Proudfoot AEI, Borlat F, Clark-Lewis I, Power CA, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997; 36:13570 - 8; http://dx.doi.org/10.1021/bi971125s; PMID: 9354625
   PubMed Web of Science ®Google Scholar
• Kjellén L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60:443 - 75; http://dx.doi.org/10.1146/annurev.bi.60.070191.002303; PMID: 1883201
   PubMed Web of Science ®Google Scholar
• Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67:609 - 52; http://dx.doi.org/10.1146/annurev.biochem.67.1.609; PMID: 9759499
   PubMed Web of Science ®Google Scholar
• Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71:435 - 71; http://dx.doi.org/10.1146/annurev.biochem.71.110601.135458; PMID: 12045103
   PubMed Web of Science ®Google Scholar
• Park PW, Reizes O, Bernfield M. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem 2000; 275:29923 - 6; http://dx.doi.org/10.1074/jbc.R000008200; PMID: 10931855
   PubMed Web of Science ®Google Scholar
• Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J, et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 2006; 7:2; http://dx.doi.org/10.1186/1471-2091-7-2; PMID: 16417632
   PubMedGoogle Scholar
• Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006; 6:633 - 43; http://dx.doi.org/10.1038/nri1918; PMID: 16917509
   PubMed Web of Science ®Google Scholar
• Iozzo RV. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 2001; 108:165 - 7; PMID: 11457866
   PubMed Web of Science ®Google Scholar
• Rops AL, van der Vlag J, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, et al. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int 2004; 65:768 - 85; http://dx.doi.org/10.1111/j.1523-1755.2004.00451.x; PMID: 14871397
   PubMed Web of Science ®Google Scholar
• Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71:481 - 539; PMID: 2006221
   PubMed Web of Science ®Google Scholar
• Couchman JR, Woods A. Syndecans, signaling, and cell adhesion. J Cell Biochem 1996; 61:578 - 84; http://dx.doi.org/10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C; PMID: 8806081
   PubMed Web of Science ®Google Scholar
• Stringer SE, Gallagher JT. Heparan sulphate. Int J Biochem Cell Biol 1997; 29:709 - 14; http://dx.doi.org/10.1016/S1357-2725(96)00170-7; PMID: 9251237
   PubMed Web of Science ®Google Scholar
• Perrimon N, Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 2000; 404:725 - 8; http://dx.doi.org/10.1038/35008000; PMID: 10783877
   PubMed Web of Science ®Google Scholar
• Gandhi NS, Mancera RL. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 2008; 72:455 - 82; http://dx.doi.org/10.1111/j.1747-0285.2008.00741.x; PMID: 19090915
   PubMed Web of Science ®Google Scholar
• Schlorke D, Thomas L, Samsonov SA, Huster D, Arnhold J, Pichert A. The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils. Carbohydr Res 2012; 356:196 - 203; http://dx.doi.org/10.1016/j.carres.2012.02.025; PMID: 22444322
   PubMed Web of Science ®Google Scholar
• Kuschert GS, Hoogewerf AJ, Proudfoot AE, Chung CW, Cooke RM, Hubbard RE, et al. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 1998; 37:11193 - 201; http://dx.doi.org/10.1021/bi972867o; PMID: 9698365
   PubMed Web of Science ®Google Scholar
• Krieger E, Geretti E, Brandner B, Goger B, Wells TN, Kungl AJ. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 2004; 54:768 - 75; http://dx.doi.org/10.1002/prot.10590; PMID: 14997572
   PubMed Web of Science ®Google Scholar
• Bitomsky W, Wade RC. Docking of glycosaminoglycans to heparin-binding proteins: validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc 1999; 121:3004 - 13; http://dx.doi.org/10.1021/ja983319g
   Web of Science ®Google Scholar
• David R, Günther R, Baumann L, Lühmann T, Seebach D, Hofmann HJ, et al. Artificial chemokines: combining chemistry and molecular biology for the elucidation of interleukin-8 functionality. J Am Chem Soc 2008; 130:15311 - 7; http://dx.doi.org/10.1021/ja802453x; PMID: 18942784
   PubMed Web of Science ®Google Scholar
• Spillmann D, Witt D, Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J Biol Chem 1998; 273:15487 - 93; http://dx.doi.org/10.1074/jbc.273.25.15487; PMID: 9624135
   PubMed Web of Science ®Google Scholar
• Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol 2005; 26:637 - 43; http://dx.doi.org/10.1016/j.it.2005.09.009; PMID: 16214414
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11:1173 - 9; http://dx.doi.org/10.1038/nm1315; PMID: 16244651
   PubMed Web of Science ®Google Scholar
• Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 2009; 86:567 - 72; http://dx.doi.org/10.1189/jlb.0109001; PMID: 19401397
   PubMed Web of Science ®Google Scholar
• Hintze V, Moeller S, Schnabelrauch M, Bierbaum S, Viola M, Worch H, et al. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 2009; 10:3290 - 7; http://dx.doi.org/10.1021/bm9008827; PMID: 19894734
   PubMed Web of Science ®Google Scholar
• Hempel U, Hintze V, Möller S, Schnabelrauch M, Scharnweber D, Dieter P. Artificial extracellular matrices composed of collagen I and sulfated hyaluronan with adsorbed transforming growth factor β1 promote collagen synthesis of human mesenchymal stromal cells. Acta Biomater 2012; 8:659 - 66; http://dx.doi.org/10.1016/j.actbio.2011.10.026; PMID: 22061106
   PubMed Web of Science ®Google Scholar
• Kunze R, Rösler M, Möller S, Schnabelrauch M, Riemer T, Hempel U, et al. Sulfated hyaluronan derivatives reduce the proliferation rate of primary rat calvarial osteoblasts. Glycoconj J 2010; 27:151 - 8; http://dx.doi.org/10.1007/s10719-009-9270-9; PMID: 19941065
   PubMed Web of Science ®Google Scholar
• Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997; 91:385 - 95; http://dx.doi.org/10.1016/S0092-8674(00)80422-5; PMID: 9363947
   PubMed Web of Science ®Google Scholar
• Carveth HJ, Bohnsack JF, McIntyre TM, Baggiolini M, Prescott SM, Zimmerman GA. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun 1989; 162:387 - 93; http://dx.doi.org/10.1016/0006-291X(89)92009-3; PMID: 2665743
   PubMed Web of Science ®Google Scholar
• Tanino Y, Coombe DR, Gill SE, Kett WC, Kajikawa O, Proudfoot AE, et al. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol 2010; 184:2677 - 85; http://dx.doi.org/10.4049/jimmunol.0903274; PMID: 20124102
   PubMed Web of Science ®Google Scholar
• Ramdin L, Perks B, Sheron N, Shute JK. Regulation of interleukin-8 binding and function by heparin and alpha2-macroglobulin. Clin Exp Allergy 1998; 28:616 - 24; http://dx.doi.org/10.1046/j.1365-2222.1998.00283.x; PMID: 9645599
   PubMed Web of Science ®Google Scholar
• Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A 1993; 90:7158 - 62; http://dx.doi.org/10.1073/pnas.90.15.7158; PMID: 8346230
   PubMed Web of Science ®Google Scholar
• Lomakina EB, Waugh RE. Signaling and dynamics of activation of LFA-1 and Mac-1 by immobilized IL-8. Cell Mol Bioeng 2010; 3:106 - 16; http://dx.doi.org/10.1007/s12195-009-0099-x; PMID: 21532911
   PubMed Web of Science ®Google Scholar
• Sengeløv H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N. Subcellular localization and dynamics of Mac-1 (α m β 2) in human neutrophils. J Clin Invest 1993; 92:1467 - 76; http://dx.doi.org/10.1172/JCI116724; PMID: 8376598
   PubMed Web of Science ®Google Scholar
• Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990; 171:1155 - 62; http://dx.doi.org/10.1084/jem.171.4.1155; PMID: 1969919
   PubMed Web of Science ®Google Scholar
• Ma YQ, Plow EF, Geng JG. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 2004; 104:2549 - 56; http://dx.doi.org/10.1182/blood-2004-03-1108; PMID: 15217824
   PubMed Web of Science ®Google Scholar
• Seo SM, McIntire LV, Smith CW. Effects of IL-8, Gro-α, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol 2001; 281:C1568 - 78; PMID: 11600420
   PubMed Web of Science ®Google Scholar
• Heit B, Colarusso P, Kubes P. Fundamentally different roles for LFA-1, Mac-1 and α4-integrin in neutrophil chemotaxis. J Cell Sci 2005; 118:5205 - 20; http://dx.doi.org/10.1242/jcs.02632; PMID: 16249234
   PubMed Web of Science ®Google Scholar
• Goger B, Halden Y, Rek A, Mösl R, Pye D, Gallagher J, et al. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 2002; 41:1640 - 6; http://dx.doi.org/10.1021/bi011944j; PMID: 11814358
   PubMed Web of Science ®Google Scholar
• Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4:394 - 400; http://dx.doi.org/10.1016/S0960-9822(00)00088-9; PMID: 7922353
   PubMed Web of Science ®Google Scholar
• Frevert CW, Kinsella MG, Vathanaprida C, Goodman RB, Baskin DG, Proudfoot A, et al. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol 2003; 28:464 - 72; http://dx.doi.org/10.1165/rcmb.2002-0084OC; PMID: 12654635
   PubMed Web of Science ®Google Scholar